New study tests antibiotic beads vs discs to save breast implants

NCT ID NCT07339215

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares two types of antibiotic carriers placed during tissue expander breast reconstruction to lower infection risk. About 100 women will receive either absorbable antibiotic beads or a non-absorbable disc, both releasing vancomycin and tobramycin. Researchers will measure antibiotic levels in breast fluid and track infections and complications for 90 days. The goal is to find which method better prevents infections that can lead to pain, extra surgeries, or loss of the reconstruction.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

antibiotic-loaded calcium sulfate beads and polymethylmethacrylate antibiotic disc (both containing vancomycin and tobramycin)

What this could lead to

If one method works better, it could reduce infections, pain, and the need for extra surgeries after breast reconstruction.

What could go wrong

This is a small, early-stage study with only 100 patients. It compares two existing methods, so neither may prove clearly better. Results may not apply to all patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TISSUE EXPANDER BASED BREAST RECONSTRUCTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Surgical Wound Infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • UC Davis Medical Center

    Sacramento, California, 95817, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••